AI
SUPN icon

Atria Investments’s Supernus Pharmaceuticals SUPN Stock Holding History

Atria Investments’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Sell
6,336
-295
-4% -$14.2K ﹤0.01% 1866
2026
Q1 		$343K Sell
6,631
-1,527
-19% -$77.8K ﹤0.01% 1668
2025
Q4 		$405K Buy
8,158
+429
+6% +$20.9K ﹤0.01% 1571
2025
Q3 		$369K Buy
7,729
+529
+7% +$21.3K ﹤0.01% 1598
2025
Q2 		$227K Buy
7,200
+157
+2% +$5.03K ﹤0.01% 1850
2025
Q1 		$231K Sell
7,043
-935
-12% -$33.1K ﹤0.01% 1754
2024
Q4 		$288K Buy
+7,978
New +$281K ﹤0.01% 1613

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Atria Investments's SUPN Position: Q2 2026 in Review

Atria Investments reduced its Supernus Pharmaceuticals (SUPN) stake by 4.4% in Q2 2026, selling an estimated $14.2K and leaving 6,336 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #1866.

Atria Investments first reported a position in SUPN in Q4 2024 and has held it in 7 quarters since. The position peaked at $405K in Q4 2025. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Atria Investments held 6,336 shares of Supernus Pharmaceuticals worth $295K as of Q2 2026.
  • Atria Investments sold 295 Supernus Pharmaceuticals shares in Q2 2026, an estimated $14.2K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1866 holding.
  • Atria Investments first reported a position in Supernus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Atria Investments's Supernus Pharmaceuticals position peaked at $405K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.